Hypertension Prevalence and Control: Impact of Method of Blood Pressure Measurement

被引:5
作者
Cloutier L. [1 ]
Schiffrin E.L. [2 ]
机构
[1] Nursing Department, Université du Québec à Trois-Rivières, Trois-Rivieres, QC
[2] Department of Medicine, B-127, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC, H3T 1E2
关键词
Blood pressure determination; Guidelines; Hypertension; Population survey;
D O I
10.1007/s12170-012-0247-z
中图分类号
学科分类号
摘要
Hypertension is a significant cause of morbidity and mortality and remains the leading risk factor for cardiovascular disease. In order to detect, diagnose, treat and follow-up hypertensive individuals, blood pressure (BP) has to be measured accurately. On a larger scale, blood pressure measurements on the whole population can generate trends that can be followed through time and be used as an indicator of a population health. Ideally, when blood pressure is measured, variability should only be attributable to the individual in whom the assessment is being performed. Nonetheless, many other factors can impact on the values obtained, namely the environment and the observer. Guidelines for BP measurement have existed for many years and are quite similar around the world, although some disparities, especially concerning devices to be used, can be noted. In research protocols, blood pressure measurement methods and thresholds used are not always properly reported, which can impact on results derived from these studies. As for prevalence estimation reported from population surveys, although changes might be needed regarding devices to replace the mercury sphygmomanometer, consideration should be given to the development of guidelines and protocols not unlike the ones used for device validation. © 2012 Springer Science+Business Media, LLC.
引用
收藏
页码:267 / 273
页数:6
相关论文
共 46 条
[1]  
Ezzati M., Et al., Selected major risk factors and global and regional burden of disease, Lancet., 360, pp. 1347-1360, (2002)
[2]  
Lewington S., Et al., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet., 360, pp. 1903-1913, (2002)
[3]  
Cushman W.C., Are there benefits to specific antihypertensive drug therapy?, Am J Hypertens., 16, (2003)
[4]  
Kearney P.M., Et al., Global burden of hypertension: analysis of worldwide data, Lancet., 365, pp. 217-223, (2005)
[5]  
Wright J.D., Et al., Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008, Nat Health Stat Rep., 35, pp. 620-626, (2011)
[6]  
Gillespie C., Kuklina E.V., Briss P.A., Blair N.A., Hong Y., Vital signs: prevalence, treatment, and control of hypertension-United States, 1999-2002 and 2005-2008, MMWR., 60, pp. 103-118, (2011)
[7]  
Bryan S., Et al., Resting blood pressure and heart rate measurement in the Canadian Health Measures Survey, cycle 1, Health Rep., 21, pp. 71-78, (2010)
[8]  
Wilkins K., Et al., Blood pressure in Canadian adults, Health Rep., 21, pp. 37-46, (2010)
[9]  
McAlister F.A., Et al., Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades, Cmaj, 183, pp. 1007-1013, (2011)
[10]  
Danaei G., Et al., National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5· 4 million participants, Lancet, 377, 9765, pp. 568-777, (2011)